Priority Date: 27.01.12 (US 201261591455P)
AMINOPYRIDINE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
- Application ID: EP13709552
- Status: █ APPLICATION DEEMED TO BE WITHDRAWN
Applicant
Technology Company
Attorney
Specialization
This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Novartis Pharma AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.
Timeline
- 27.01.2012 - Priority Date (US 201261591455P)
- 01.08.2013 - Publication A1 (WO2013111107)
- 03.12.2014 - Publication A1 (EP2807156)